Malignite şüpheli veya foliküler tiroid lezyonlarında Tc99m sestamibi görüntüleme

Amaç: Bu çalışmamızda tiroid ince iğne aspirasyon biyopsisi (İİAB) sonucunda malignite açısından şüpheli veya foliküler lezyon saptanan nodüllerde maligniteyi tespit edebilmek için bir tümör ajanı olan Tc99m sestamibi kullanılabilirliğini inceledik. Yöntem: 24 hastada İİAB değerlendirmesinde malignite açısından şüpheli veya foliküler sitopatoloji saptandı ve bunlardan 13 tanesine Tc99m sestamibi ile görüntüleme yapıldıktan sonra tiroidektomi uygulandı. Sestamibi görüntüleme, İİAB ve histopatoloji sonuçları karşılaştırmalı olarak incelendi. Bulgular: Onikisi kadın, toplam 13 hasta çalımaya dahil edildi. Ortalama yaş 44,9±12,6 (29-77) idi. 10 (% 76,9) hastada malignite açısından şüpheli sitoloji, 3 (%23,1) hastada foliküler lezyon vardı. Histopatolojik incelemede 6 hastada papiller, 1 hastada foliküler, 1 hastada medüller, 4 hastada benign kistik guatr, 1 hastada ise lenfositik tiroidit saptandı. Medüller tiroid kanserli 1 olgu dışındaki tüm malign hastalarda (6 papiller ve 1 foliküler kanser) sestamibi tutulumu saptanırken, benign kistik guatrlı 4 olgudan birinde ve lenfositik tiroiditli 1 olguda sestamibi pozitif saptandı. Ortalama nodül çapı 26,9±20,1 mm idi (benign olanlarda 23,6±6.87 mm, malign olanlarda 29,28±26,45 mm, p>0.05). Sonuç: Tc99m sestamibi’nin sensitivite ve spesifitesi sırasıyla % 75 ve % 60, pozitif ve negatif prediktif değerler sırasıyla 0,75 ve 0,60 olarak bulundu. Bu konuda daha geniş hasta grupları içeren çalışmalara ihtiyaç olduğu kanaatine varıldı.

Tc99m sestamibi imaging in malignancy suspected or thyroid follicular lesions

Objective: In this study we evaluated the usefullness of Tc99msestamibi, a tumor agent, to detect malignancy for nodules reported as “SFM” and “ITFL”. Methods: Thirteen of 24 cases, reported as “SFM” or “ITFL” by FNAB, underwent bilateral total thyroidectomy after imaging by Tc99msestamibi. Then, Tc99msestamibi imaging, FNAB and hystopathologic results were compared. Results: There were only one male and the mean age was 44,9±12,6 (29-77). We detected “SFM” in 10 (76,9%) cases, and “TFL” in 3 (23,1%) cases. By hystopathologic investigation 6 papillary, 1 follicular, 1 medullary, 4 benign cystic goiter and 1 lymhocytic thyroiditis detected. There was MIBI uptake in all cases with malignancy, except one with medullary thyroid cancer (6 papillary and one follicular cancer). MIBI uptake was detected also in one of four cases with benign cystic gioter and one case with lynphocytic goiter. The mean nodule diameter was 26,9±20,1 mm (23,6±6.87 mm in benign cases, 29,28±26,45 mm in malignant cases, p>0.05). Conclusion: The sensitivity, specifity, pozitive and negative predictive value of of Tc99msestamibi were 75% and 60%, 0,75 ve 0,60, respectively. As conclusion, to determine the usefulness of Tc99msestamibi for detecting malignancy in nodules reported as “SFM” or “ITFL” by FNAB, more studies with larger populations should be performed.

___

  • 1. Koloğlu S,Türkiye’de endemik guatr. Ankara; Hacettepe-Taş Kitabevi;1984.
  • 2. Yalın R, Dülger M, Oğuz M,Gültekin A, Yıldırım C, Temizkan N. Endemik bir guatr bölgesindeki araştırma sonuçları. Çağdaş Cerrahi Derg 1987;3:197-200.
  • 3. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2009;19:1167- 214.
  • 4. Castro MR, Gharib H. Thyroid fine-needle aspiration biopsy: progress, practice, and pitfalls. Endocr Pract 2003;9:128-36.
  • 5. Baloch ZW, Fleisher S, LiVolsi VA, Gupta PK. Diagnosis of ‘‘follicular neoplasm’’: A gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 2002;26:41-44.
  • 6. Hurtado-Lopez LM, Arellano-Montano S, Torres-Acosta EM, et al. Combined use of fine-needle aspiration biopsy, MIBI scans and frozen section biopsy offersthe best diagnostic accuracy in the assessment of the hypofunctioning solitary thyroid nodule. Eur J Nucl Med Mol Imaging 2004;31:1273-9.
  • 7. Boi F, Lai ML, Deias C, Piga M. The usefulness of 99m Tc- SestaMIBI scan in the diagnostic evaluation of thyroid nodules with oncocytic cytology. European J Endoc 2003;149:493-8.
  • 8. Kao CH, Wang SJ, Liao SQ, Lin WY, Hsu CY. Quick diagnosis of hyperthyroidism with semiquantitative 30-minute technetium-9 9m-methoxy-isobutyl-isonitrile thyroid uptake. J Nucl Med 1993;34:71-4.
  • 9. Moretti JL, Hauet N, Caglar M, Rebillard O, Burak Z. To use MIBI or not to use MIBI? That is the question when assessing tumour cells. Eur J Nucl Med Mol Imaging 2005;32:836–42.
  • 10. Piwnica-Worms DP, Kronauge JF, LeFurgey A. Mitochondrial localization and characterization of 99Tcsestamibi in heart cells by electron probe X-ray microanalysis and 99Tc-NMR spectroscopy. Magn Reson Imaging 1994;12:641–52.
  • 11. Passler C, Prager M, Scheuba C, Kaserer K, Flores JA, Vierhapper H, Niederle B. The value of fine-needle Aspiration biopsy (FNAB) in the differential diagnosis of the “cold” thyroid nodule. Wien Klin Wochenschr 1999; 111:240–5.
  • 12. Kim EK, Park CS, Chung WY, Oh KK, Kim DI, Lee JT, et al. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. AJR Am J Roentgenol 2002;178:687-91.
  • 13. Moon WJ, Jung SL, Lee JH, Na DG, Baek JH, Lee YH, et al. Benign and malignant thyroid nodules: US differentiationmulticenter retrospective study. Radiology 2008;247:762-70.
  • 14. Duran C, Saraydaroglu O, Ersoy C, Selimoglu H, Kiyici S, Oz O, Tuncel E, Imamoglu S. Tumor size predictive for the indeterminate follicular thyroid lesions. The Endocrinologist, 2006;16:313-6.
  • 15. Erturk E, Saraydaroğlu O, Kiyici S, Ersoy C, Yerci O, Duran C, Imamoglu S, Tuncel E. “Galectin-3 Highly expressed in well differantiated thyroid carcinoma, is also expressed weakly but frequently in follicular adenomas. 30Th Annual Meeting of the European Thyroid Association, September 18- 22, 2004, İstanbul, Abstract
  • 16. Saggiorato E, Angusti T, Rosas R, Martinese M, Finessi M. 99mTc-MIBI imaging in the presurgical characterization of thyroid follicular neoplasms: relationship to multidrug resistance protein expression. J Nucl Med 2009;50:1785-93.